109-01-3 | 1-Methylpiperazine

Packsize	Purity	Availability	Price	Discounted Price
10g	98%	in stock	$13.00	$9.00
25g	98%	in stock	$20.00	$14.00
100g	98%	in stock	$46.00	$32.00

Description

• Catalog Number: AB43415
• Chemical Name: 1-Methylpiperazine
• CAS Number: 109-01-3
• Molecular Formula: C5H12N2
• Molecular Weight: 100.1622
• MDL Number: MFCD00005966
• SMILES: CN1CCNCC1

Computed Properties

• Complexity: 48
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 7
• Hydrogen Bond Acceptor Count: 2
• Hydrogen Bond Donor Count: 1
• XLogP3: -0.4

Upstream Synthesis Route

1-Methylpiperazine, also known as N-methylpiperazine, is a versatile chemical compound widely used in various chemical synthesis processes. This compound serves as an important building block in the pharmaceutical industry, as it is commonly utilized in the synthesis of various drugs and active pharmaceutical ingredients (APIs). Due to its unique structure and reactivity, 1-Methylpiperazine is employed as a key intermediate in the production of antihistamines, antipsychotics, and other therapeutic agents. Its presence in the molecular structure of these pharmaceutical compounds plays a crucial role in enhancing their biological activity and pharmacological properties.Furthermore, 1-Methylpiperazine is utilized in the preparation of specialty chemicals, such as corrosion inhibitors, surfactants, and agrochemicals. Its ability to participate in diverse chemical reactions, including alkylation, acylation, and cross-coupling reactions, makes it a valuable tool in organic synthesis.Overall, 1-Methylpiperazine's significance lies in its versatility and importance as a key component in chemical synthesis, particularly in the pharmaceutical and specialty chemical industries. Its varied applications highlight its essential role in the development of innovative and life-saving products.

Literature

• Disposition and metabolism of 14C-dovitinib (TKI258), an inhibitor of FGFR and VEGFR, after oral administration in patients with advanced solid tumors.

  Cancer chemotherapy and pharmacology 20121101

• Toward rational design of amine solutions for PCC applications: the kinetics of the reaction of CO2(aq) with cyclic and secondary amines in aqueous solution.

  Environmental science & technology 20120703

• Simultaneous determination of four plant hormones in bananas by molecularly imprinted solid-phase extraction coupled with high performance liquid chromatography.

  The Analyst 20120621

• 5-Methyl-3,3-bis-(4-methyl-piperazin-1-yl)-1-[2-(4-methyl-piperazin-1-yl)eth-yl]indolin-2-one.

  Acta crystallographica. Section E, Structure reports online 20120601

• 12-{[4-(2-Fluoro-phen-yl)piperazin-1-yl]-meth-yl}-9α-hy-droxy-4,8-dimethyl-3,14-dioxatricyclo-[9.3.0.0]tetra-dec-7-en-13-one.

  Acta crystallographica. Section E, Structure reports online 20120301

• Novel benzothiazole, benzimidazole and benzoxazole derivatives as potential antitumor agents: synthesis and preliminary in vitro biological evaluation.

  Molecules (Basel, Switzerland) 20120117

• Discovery of a novel class of orally active trypanocidal N-myristoyltransferase inhibitors.

  Journal of medicinal chemistry 20120112

• Divalent-metal-stabilized aluminophosphates exhibiting a new zeolite framework topology.

  Inorganic chemistry 20120102

• New N-methylpiperazinyl derivatives of bicyclic antiprotozoal compounds.

  European journal of medicinal chemistry 20120101

• 2-(5-Fluoro-2,3-dioxoindolin-1-yl)ethyl 4-methyl-piperazine-1-carbodithio-ate.

  Acta crystallographica. Section E, Structure reports online 20120101

• Structure and electronic properties of Alq3 derivatives with electron acceptor/donor groups at the C4 positions of the quinolate ligands: a theoretical study.

  Journal of molecular modeling 20111201

• (2R)-4-[(9H-Fluoren-9-ylmeth-oxy)carbon-yl]-2-methyl-piperazin-1-ium chloride.

  Acta crystallographica. Section E, Structure reports online 20111201

• Polymorphic form IV of olanzapine.

  Acta crystallographica. Section C, Crystal structure communications 20111101

• 1-Methyl-piperazine-1,4-diium tetra-chloridozincate hemihydrate.

  Acta crystallographica. Section E, Structure reports online 20111101

• 4-(4-Methyl-piperazin-1-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)-7-(trifluoro-meth-yl)quinoline.

  Acta crystallographica. Section E, Structure reports online 20111101

• Influence of pharmacogenetic variability on the pharmacokinetics and toxicity of the aurora kinase inhibitor danusertib.

  Investigational new drugs 20111001

• Determination of ofloxacin and lomefloxacin in chicken muscle using molecularly imprinted solid-phase extraction coupled with liquid chromatography.

  Journal of separation science 20111001

• N-(4-Chloro-phen-yl)-4-methyl-piperazine-1-carboxamide.

  Acta crystallographica. Section E, Structure reports online 20110901

• Bis(1-methyl-piperazine-1,4-diium) tetra-bromidocuprate(II).

  Acta crystallographica. Section E, Structure reports online 20110701

• Bis(1-methyl-piperazine-1,4-diium) tetra-chloridocuprate(II).

  Acta crystallographica. Section E, Structure reports online 20110701

• Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moiety.

  Bioorganic & medicinal chemistry 20110401

• 5-Nitroimidazole-based 1,3,4-thiadiazoles: heterocyclic analogs of metronidazole as anti-Helicobacter pylori agents.

  Archiv der Pharmazie 20110301

• Synthesis of 1H-pyrazole-1-carboxamide derivatives and their antiproliferative activity against melanoma cell line.

  Archiv der Pharmazie 20110301

• 1-[4-(3-{[5-(4-Chloro-phen-yl)furan-2-yl]methyl-idene-amino}-2,5-dioxoimidazol-idin-1-yl)but-yl]-4-methyl-piperazine-1,4-diium dichloride hemihydrate.

  Acta crystallographica. Section E, Structure reports online 20110201

• Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia.

  Cancer management and research 20110101

• Studies on the anthelmintic property of aminobenzylated mannich bases.

  Journal of young pharmacists : JYP 20110101

• Combined pharmacophore modeling, docking, and 3D-QSAR studies of PLK1 inhibitors.

  International journal of molecular sciences 20110101

• 3D QSAR pharmacophore modeling, in silico screening, and density functional theory (DFT) approaches for identification of human chymase inhibitors.

  International journal of molecular sciences 20110101

• Tetrasubstituted naphthalene diimide ligands with selectivity for telomeric G-quadruplexes and cancer cells.

  Bioorganic & medicinal chemistry letters 20101115

• Novel tricyclic pyrazole BRAF inhibitors with imidazole or furan central scaffolds.

  Bioorganic & medicinal chemistry 20100915

• Peptidyl alpha-ketoamides with nucleobases, methylpiperazine, and dimethylaminoalkyl substituents as calpain inhibitors.

  Journal of medicinal chemistry 20100909

• In vitro and in vivo studies of the trypanocidal properties of WRR-483 against Trypanosoma cruzi.

  PLoS neglected tropical diseases 20100901

• catena-Poly[(S)-2-methyl-piperazine-1,4-diium [[trichloridobismuthate(III)]-di-μ-chlorido]].

  Acta crystallographica. Section E, Structure reports online 20100901

• Chalcogenides of the aminomethylphosphines derived from 1-methylpiperazine, 1-ethylpiperazine and morpholine: NMR, DFT and structural studies for determination of electronic and steric properties of the phosphines.

  Dalton transactions (Cambridge, England : 2003) 20100828

• Determination of individual proton affinities of ofloxacin from its UV-Vis absorption, fluorescence and charge-transfer spectra: effect of inclusion in beta-cyclodextrin on the proton affinities.

  The journal of physical chemistry. B 20100805

• Crystal Structures of TbCatB and rhodesain, potential chemotherapeutic targets and major cysteine proteases of Trypanosoma brucei.

  PLoS neglected tropical diseases 20100601

• Streamlined, automated protocols for the production of milligram quantities of untagged recombinant human cyclophilin-A (hCypA) and untagged human proliferating cell nuclear antigen (hPCNA) using AKTAxpress.

  Protein expression and purification 20100501

• A statistics-based platform for quantitative N-terminome analysis and identification of protease cleavage products.

  Molecular & cellular proteomics : MCP 20100501

• Synthesis and antimicrobial activities of some new 1,2,3-triazole derivatives.

  Molecules (Basel, Switzerland) 20100408

• Conjugate addition of nucleophiles to the vinyl function of 2-chloro-4-vinylpyrimidine derivatives.

  Molecules (Basel, Switzerland) 20100319

• Detection of nitric oxide in tissue samples by ESI-MS.

  The Analyst 20100201

• Sulfonamide-1,2,4-thiadiazole derivatives as antifungal and antibacterial agents: synthesis, biological evaluation, lipophilicity, and conformational studies.

  Chemical & pharmaceutical bulletin 20100201

• Imatinibium dipicrate.

  Acta crystallographica. Section E, Structure reports online 20100201

• Synthesis and biological evaluation of N-hydroxyphenylacrylamides and N-hydroxypyridin-2-ylacrylamides as novel histone deacetylase inhibitors.

  Journal of medicinal chemistry 20100128

• Theoretical and experimental studies of the isomeric protonation in solution for a prototype aliphatic ring containing two nitrogens.

  The journal of physical chemistry. B 20100114

• Novel imatinib derivatives with altered specificity between Bcr-Abl and FMS, KIT, and PDGF receptors.

  ChemMedChem 20100101

• [Synthesis, modifications, and antimicrobial activity of the methylpiperazinyl amides of triterpenic acids].

  Bioorganicheskaia khimiia 20100101

• [Synthesis and pharmacological activity of amides and ozonolysis product of maleopimaric acid].

  Bioorganicheskaia khimiia 20100101

• Solution structure of a covalently bound pyrrolo[2,1-c][1,4]benzodiazepine-benzimidazole hybrid to a 10mer DNA duplex.

  Biochemistry 20091229

• [2-(4-Methyl-piperazin-1-ylmeth-yl)phen-yl]diphenyl-phosphane.

  Acta crystallographica. Section E, Structure reports online 20091201

• Regioselective reaction: synthesis and pharmacological study of Mannich bases containing ibuprofen moiety.

  European journal of medicinal chemistry 20090901

• Synthesis of some new 1,3,4-thiadiazol-2-ylmethyl-1,2,4-triazole derivatives and investigation of their antimicrobial activities.

  European journal of medicinal chemistry 20090701

• Discovery of substituted N'-(2-oxoindolin-3-ylidene)benzohydrazides as new apoptosis inducers using a cell- and caspase-based HTS assay.

  Bioorganic & medicinal chemistry letters 20090515

• Manipulation of fluorescent and colorimetric changes of fluorescein derivatives and applications for sensing silver ions.

  Chemical communications (Cambridge, England) 20090314

• Synthesis of some new 1,2,4-triazoles, their Mannich and Schiff bases and evaluation of their antimicrobial activities.

  European journal of medicinal chemistry 20090301

• Synthesis and spectral characterization of a new class of N-(N-methylpiperazinoacetyl)-2,6-diarylpiperidin-4-ones: antimicrobial, analgesic and antipyretic studies.

  European journal of medicinal chemistry 20090201

• Structure elucidation of thioketone analogues of sildenafil detected as adulterants in herbal aphrodisiacs.

  Journal of pharmaceutical and biomedical analysis 20090115

• Hoechst 33342: the dye that enabled differentiation of living X-and Y-chromosome bearing mammalian sperm.

  Theriogenology 20090101

• The structure of the leukemia drug imatinib bound to human quinone reductase 2 (NQO2).

  BMC structural biology 20090101

• The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism.

  Nuclear receptor signaling 20090101

• Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.

  PloS one 20090101

• Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib.

  Drug design, development and therapy 20090101

• Proteomics: challenges, techniques and possibilities to overcome biological sample complexity.

  Human genomics and proteomics : HGP 20090101

• Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H4 receptor ligands.

  Journal of medicinal chemistry 20081023

• Copper(I) cyanide networks: synthesis, structure, and luminescence behavior. Part 2. Piperazine ligands and hexamethylenetetramine.

  Inorganic chemistry 20080804

• Use of N-methylpiperazine for the preparation of piperazine-based unsymmetrical bis-ureas as anti-HIV agents.

  ChemMedChem 20080701

• Gene expression signatures and small-molecule compounds link a protein kinase to Plasmodium falciparum motility.

  Nature chemical biology 20080601

• 3-(4-Methyl-piperazin-1-yl)isobenzofuran-1(3H)-one.

  Acta crystallographica. Section E, Structure reports online 20080501

• Morpholine-based immonium and halogenoamidinium salts as coupling reagents in Peptide synthesis1.

  The Journal of organic chemistry 20080404

• Determination of analogs of sildenafil and vardenafil in foods by column liquid chromatography with a photodiode array detector, mass spectrometry, and nuclear magnetic resonance spectrometry.

  Journal of AOAC International 20080101

• Improved proteome coverage by using iTRAQ labelling and peptide OFFGEL fractionation.

  Proteome science 20080101

• Crystal structures of the FAK kinase in complex with TAE226 and related bis-anilino pyrimidine inhibitors reveal a helical DFG conformation.

  PloS one 20080101

• Development and targeted use of nilotinib in chronic myeloid leukemia.

  Drug design, development and therapy 20080101

• Synthesis and Pharmacological Evaluation of (6-Substituted 4-Oxo-4H-chromene-3 yl) methyl N-substituted Aminoacetates.

  Indian journal of pharmaceutical sciences 20080101

• Refining targeted therapies in chronic myeloid leukemia: development and application of nilotinib, a step beyond imatinib.

  OncoTargets and therapy 20080101

• N-Methyl-piperazinediium penta-chloridoanti-monate(III) monohydrate.

  Acta crystallographica. Section E, Structure reports online 20080101

• Use of liquid chromatography-mass spectrometry and a chemical cleavage reaction for the structure elucidation of a new sildenafil analogue detected as an adulterant in an herbal dietary supplement.

  Journal of pharmaceutical and biomedical analysis 20070815

• Synthesis of o-sulfamidotriazobenzenes from 1,1'-sulfonylbis(benzotriazole).

  The Journal of organic chemistry 20070720

• DFT and ab initio calculations of the vibrational frequencies and visible spectra of triazenes derived from cyclic amines.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20070601

• Quinazolinone fungal efflux pump inhibitors. Part 3: (N-methyl)piperazine variants and pharmacokinetic optimization.

  Bioorganic & medicinal chemistry letters 20070515

• Structure elucidation of a novel analogue of sildenafil detected as an adulterant in an herbal dietary supplement.

  Journal of pharmaceutical and biomedical analysis 20070411

• Structure determination of new analogues of vardenafil and sildenafil in dietary supplements.

  Food additives and contaminants 20070201

• Array-based split-pool combinatorial screening of potential catalysts.

  Journal of combinatorial chemistry 20070101

• Precise protein quantification based on peptide quantification using iTRAQ.

  BMC bioinformatics 20070101

• NS-187 (INNO-406), a Bcr-Abl/Lyn dual tyrosine kinase inhibitor.

  Analytical chemistry insights 20070101

• Synthesis and antitumor activity of CBI-bearing ester and carbamate prodrugs of CC-1065 analogue.

  Bioorganic & medicinal chemistry 20061201

• Acenaphtho[1,2-b]pyrrole derivatives as new family of intercalators: various DNA binding geometry and interesting antitumor capacity.

  Bioorganic & medicinal chemistry 20061015

• 7-(aryl/heteroaryl-2-ylethynyl)-4-phenylamino-3-quinolinecarbonitriles as new Src kinase inhibitors: addition of water solubilizing groups.

  Bioorganic & medicinal chemistry letters 20060801

• Photoaddition of N-substituted piperazines to C60: an efficient approach to the synthesis of water-soluble fullerene derivatives.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20060717

• Phenothiazine molecule provides the basic chemical structure for various classes of pharmacotherapeutic agents.

  American journal of therapeutics 20060101

• Synthesis and characterization of water-soluble phenylene-vinylene-based singlet oxygen sensitizers for two-photon excitation.

  The Journal of organic chemistry 20050902

• Structural disorder in the complex of human pregnane X receptor and the macrolide antibiotic rifampicin.

  Molecular endocrinology (Baltimore, Md.) 20050501

• Analysis of cell membrane aminophospholipids as isotope-tagged derivatives.

  Journal of lipid research 20050501

• Identification of a 5-HT4 receptor antagonist clinical candidate through side-chain modification.

  Bioorganic & medicinal chemistry letters 20050315

• Identification of 4-methylspinaceamine--a Pictet-Spengler condensation reaction product of histamine with acetaldehyde--in human urine.

  Life sciences 20050128

• N-Chloroacyl-6-O-triphenylmethylchitosans: useful intermediates for synthetic modifications of chitosan.

  Biomacromolecules 20050101

• Structure determination of a sildenafil analogue contained in commercial herb drinks.

  Magnetic resonance in chemistry : MRC 20041201

• 1-Methylpiperazine-1,4-diium 4-nitrophthalate(2-) 4-nitrophthalic acid monohydrate.

  Acta crystallographica. Section C, Crystal structure communications 20040901

• Solid-phase synthesis and evaluation of libraries of substituted 4,5-dihydropyridazinones as vasodilator agents.

  The Journal of pharmacy and pharmacology 20040801

• Structure elucidation of sildenafil analogues in herbal products.

  Food additives and contaminants 20040801

• DNA binding to guide the development of tetrahydroindeno[1,2-b]pyrido[4,3,2-de]quinoline derivatives as cytotoxic agents.

  Journal of medicinal chemistry 20040701

• Isoelectric point separation of proteins by capillary pH-gradient ion-exchange chromatography.

  Journal of chromatography. A 20040206

• DNA-directed alkylating agents: synthesis, antitumor activity and DNA affinity of bis-N,N'-trisubstituted 1,2,4-triazolo-piperazines.

  Farmaco (Societa chimica italiana : 1989) 20040101

• [New derivatives of triazino- and imidazoindole with hepatoprotective activity].

  Biomeditsinskaia khimiia 20040101

• Physicochemical determinants for drug induced blockade of HERG potassium channels: effect of charge and charge shielding.

  Current medicinal chemistry. Cardiovascular and hematological agents 20031001

• Solid-phase parallel synthesis of 17alpha-substituted estradiol sulfamate and phenol libraries using the multidetachable sulfamate linker.

  Journal of combinatorial chemistry 20030101

• Mechanistic insights into the Pd(BINAP)-catalyzed amination of aryl bromides: kinetic studies under synthetically relevant conditions.

  Journal of the American Chemical Society 20021127

• New pyridobenzodiazepine derivatives: modifications of the basic side chain differentially modulate binding to dopamine (D(4.2), D(2L)) and serotonin (5-HT(2A)) receptors.

  Journal of medicinal chemistry 20021107

• 2,4-Disubstituted pyrroles: synthesis, traceless linking and pharmacological investigations leading to the dopamine D4 receptor partial agonist FAUC 356.

  Bioorganic & medicinal chemistry letters 20020805

• NMR characterization of the DNA binding properties of a novel Hoechst 33258 analogue peptide building block.

  Bioconjugate chemistry 20020101

• The interaction of 2-phenylbenzimidazole compounds with DNA: the influence of terminal substituents.

  Nucleic acids research. Supplement (2001) 20020101

• Optimization of 4-phenylamino-3-quinolinecarbonitriles as potent inhibitors of Src kinase activity.

  Journal of medicinal chemistry 20011108

• Tris-benzimidazole derivatives: design, synthesis and DNA sequence recognition.

  Bioorganic & medicinal chemistry 20011101

• Tertiary N-glucuronides of clozapine and its metabolite desmethylclozapine in patient urine.

  Drug metabolism and disposition: the biological fate of chemicals 20011001

• Ofloxacin/beta-cyclodextrin complexation.

  Drug development and industrial pharmacy 20010701